VLKOVÁ, Marcela, Zita CHOVANCOVÁ, Jana NECHVÁTALOVÁ, Ashley Nicole CONNELLY, Marcus Darrell DAVIS, Peter SLANINA, Lucie KUČEROVÁ, Marek LITZMAN, Tereza GRYMOVÁ, Přemysl SOUČEK, Tomáš FREIBERGER, Jiří LITZMAN and Zdenek HEL. Neutrophil and Granulocytic Myeloid-Derived Suppressor Cell-Mediated T Cell Suppression Significantly Contributes to Immune Dysregulation in Common Variable Immunodeficiency Disorders. Journal of immunology. Bethesda: American association of immunologists, 2019, vol. 202, No 1, p. 93-104. ISSN 0022-1767. Available from: https://dx.doi.org/10.4049/jimmunol.1800102.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Neutrophil and Granulocytic Myeloid-Derived Suppressor Cell-Mediated T Cell Suppression Significantly Contributes to Immune Dysregulation in Common Variable Immunodeficiency Disorders
Authors VLKOVÁ, Marcela (203 Czech Republic, guarantor, belonging to the institution), Zita CHOVANCOVÁ (203 Czech Republic, belonging to the institution), Jana NECHVÁTALOVÁ (203 Czech Republic, belonging to the institution), Ashley Nicole CONNELLY (840 United States of America), Marcus Darrell DAVIS (840 United States of America), Peter SLANINA (703 Slovakia, belonging to the institution), Lucie KUČEROVÁ (203 Czech Republic, belonging to the institution), Marek LITZMAN (203 Czech Republic), Tereza GRYMOVÁ (203 Czech Republic, belonging to the institution), Přemysl SOUČEK (203 Czech Republic, belonging to the institution), Tomáš FREIBERGER (203 Czech Republic, belonging to the institution), Jiří LITZMAN (203 Czech Republic, belonging to the institution) and Zdenek HEL (203 Czech Republic).
Edition Journal of immunology, Bethesda, American association of immunologists, 2019, 0022-1767.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30102 Immunology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 4.886
RIV identification code RIV/00216224:14110/19:00108489
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.4049/jimmunol.1800102
UT WoS 000454422600011
Keywords in English Common variable immunodeficiency disorders
Tags 14110114, podil, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Pavla Foltynová, Ph.D., učo 106624. Changed: 9/3/2020 09:28.
Abstract
Common variable immunodeficiency disorders (CVID) represent a group of primary immunodeficiency diseases characterized by hypogammaglobulinemia and impaired specific Ab response, resulting in recurrent infections due to dysfunctional immune response. The specific mechanisms mediating immune deficiency in CVID remain to be determined. Previous studies indicated that immune dysregulation in CVID patients is associated with chronic microbial translocation, systemic immune activation, and altered homeostasis of lymphocytic and myeloid lineages. A detailed phenotypic, functional characterization of plasma markers and immune cell populations was performed in 46 CVID patients and 44 healthy donors. CVID patients displayed significantly elevated plasma levels of a marker of neutrophil activation neutrophil gelatinase-associated lipocalin. Neutrophils from CVID patients exhibited elevated surface levels of CD11b and PD-L1 and decreased levels of CD62L, CD16, and CD80, consistent with a phenotype of activated neutrophils with suppressive properties. Neutrophils from CVID patients actively suppressed T cell activation and release of IFN-gamma via the production of reactive oxygen species. Furthermore, CVID was associated with an increased frequency of low-density neutrophils (LDNs)/granulocytic myeloid-derived suppressor cells. LDN/granulocytic myeloid-derived suppressor cell frequency in CVID patients correlated with reduced T cell responsiveness. Exogenous stimulation of whole blood with bacterial LPS emulated some but not all of the phenotypic changes observed on neutrophils from CVID patients and induced neutrophil population with LDN phenotype. The presented data demonstrate that neutrophils in the blood of CVID patients acquire an activated phenotype and exert potent T cell suppressive activity. Specific targeting of myeloid cell-derived suppressor activity represents a novel potential therapeutic strategy for CVID.
Links
NV15-28732A, research and development projectName: Vliv granulocytů a monocytů na vznik a rozvoj imunodeficitních chorob a dalších imunopatologických dějů
PrintDisplayed: 26/4/2024 10:12